Regeneron Pharmaceuticals, Inc 10-Q for FY2020 Q3
Regeneron Pharmaceuticals, Inc. (REGN)
10-Q
2020-11-05
For: 2020-09-30
View Original
Added on
April 08, 2026
About this 10-Q
Regeneron Pharmaceuticals, Inc filed this 10-Q on November 5, 2020, covering the quarter ended September 30, 2020 (FY2020 Q3).
Headline figures
Quarter ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.29B
- up 31.6% from $1.74B a year earlier
- Net income
- $842.1M
- up 25.8% from net income of $669.6M a year earlier
- Diluted EPS
- $7.39
- up 26.1% from $5.86 a year earlier